Clinical Trial Update: Fecal Transplantation for Primary Clostridium Difficile Infection [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating fecal microbiota transplantation for primary Clostridioides difficile infection has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Clostridioides Difficile Infection

Drugs mentioned

• Fecal microbiota transplantation (fecal microbiota transplantation)

Snippet

Sponsor: Oslo University Hospital | Conditions: Clostridium Difficile Infection | Phase 3 | Status: TERMINATED